Rheumatoid Arthritis Clinical Trials in Houston

Showing 2041-2060 of 2,948 trials

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

NCT00597818

The primary purpose of this study is to determine the efficacy and safety of three dose levels of cobiprostone as compared to placebo in OA/RA patients treated with an NSAID for 20 months.

NSAID-induced Gastroduodenal InjuryUlcersRheumatoid Arthritis+1 more

Sucampo Pharma Americas, LLC121 participantsStarted Aug 2007

Phoenix, Arizona, United States • Chula Vista, California, United States • Loma Linda, California, United States +16 more locations

COMPLETEDPhase 3< 1 mile

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT01578707

The purpose of the study is to evaluate whether treatment with ibrutinib as a monotherapy results in a clinically significant improvement in progression free survival (PFS) as compared to treatment with ofatumumab in patients with relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Relapsed or Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Pharmacyclics LLC.391 participantsStarted Jun 2012

La Jolla, California, United States • Los Angeles, California, United States • Santa Maria, California, United States +73 more locations

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Rheumatoid Arthritis Trials in Other Cities

EEG Based BCI for Upper Limb Rehabilitation in Stroke

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

SPRINT - Randomized Trial of Tibial Fracture Fixation

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ImageReady(TM) MR Conditional Pacing System Clinical Study

EverFlex Post Approval Study

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

MaxAn Post Market Surveillance Validation

Post Market Surveillance Study of the Wingspan Stent System

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

A Clinical Trial of IntensiVE Dialysis

Other Conditions in Houston